Company: AMTX
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0001437749-25-033667
Chunk: 24

Company: AEMETIS, INC
Filing Date: 2025-11-07
Form: 10-Q
Item: Part I, Item 1
Chunk 24
---
 the expected life of the option. We use an expected dividend yield of zero, as we do
      not anticipate paying any dividends in the foreseeable future. Expected forfeitures are assumed to be
      zero due to the small number of plan participants. To the extent actual forfeitures occur, the difference is recorded as an adjustment in the scheduled expense during the period of the forfeiture.

       The weighted average fair value calculations for the options granted during the 
      nine months ended  September 30, 2025 and 2024, are based on the following assumptions:

       For the nine months ended September 30,  
 Description   2025    2024  
 Dividend-yield   -%  -%
 Risk-free interest rate   4.29%  3.93%
 Expected volatility   113.50%  115.42%
 Expected life (years)   5.81   5.81 
 Market value per share on grant date  $2.73  $3.10 
 Fair value per option on grant date  $2.32  $2.65 

       During the 
      nine months ended  September 30, 2025 and 2024, we granted 
      396 thousand and 
      364 thousand shares of common stock under the
      2019 Stock Plan, respectively, with a fair value on date of grant of 
      $2.73 and
      $3.10, respectively, per share.

       As of 
       September 30, 2025, we
       had
      $4.7 million of total unrecognized compensation expense for option issuances, which we will amortize over the remaining vesting period for each applicable grant, which has a weighted average of 
      1.91 years as of
       September 30, 2025.

       16

        (Tabular data in thousands, except par value and per share data)

   10. Warrants to Purchase Common Stock
    
   On  June 30, 2025, the maturity dates on two accredited investor's Subordinated Notes were extended to  December 31, 2025. In connection with the extension, we issued the noteholders warrants exercisable for the purchase of 113 thousand shares of Aemetis, Inc. common stock with a term of two years and an exercise price of $0.